Cell>Point News & Publications

Diagnostic Imaging

News

Cell>Point adds Steven Hanley to Board of Advisors – 6/18/2009

Posted on: April 14th, 2012

CENTENNIAL, Colo., June 18, 2009 – Cell>Point is pleased to announce that Steve Hanely has joined our Board of Advisors. Mr. Hanley is a former President of the Global Imaging Division of Covidien . Mr. Hanley earned his MBA and BS, Business Administration from Marquette University.

Read More

Cell>Point adds Dr. Eric Kurzweil to Board of Advisors – 9/11/2008

Posted on: April 14th, 2012

CENTENNIAL, Colo., September 11, 2008 – Cell>Point is pleased to announce that Eric Kurzweil, M.D., MBA has joined our Board of Advisors. Dr. Kurzweil is currently President of the Rocky Mountain Region of Pediatrix. Pediatrix, a $2.63 billion market cap company listed on the NYSE:PDX which includes more than 900 physicians nationwide. Dr. Kurzweil received…

Read More

Cell>Point establishes European subsidiary — 7|1|08

Posted on: April 14th, 2012

CENTENNIAL, Colo., July 1, 2008 – Cell>Point announced today that it has established a subsidiary in the Netherlands, Cell>Point Netherlands BV. Cell>Point plans to expand its operation in Europe including financial partners and European clinical trial sites for its Phase III clinical trials in 99mTc-EC-G.

Read More

Cell>Point to present at Wachovia 2008 Healthcare Conference — 1|25|08

Posted on: April 14th, 2012

CENTENNIAL, Colo., January 25, 2008 – Cell>Point, L.L.C. today announced that it will present at the Wachovia 2008 Healthcare Conference, which will be held January 29-31, 2008, at The Langham Hotel in Boston, Mass. Cell>Point will present Thursday, January 31 at 1:00 pm (Eastern Time) in the Palmer Room.

Read More

Dr. F. David Rollo joins Cell>Point as President — 9|12|06

Posted on: April 14th, 2012

CENTENNIAL, Colo., September 12, 2006 Cell>Point today announced F. David Rollo, M.D., Ph.D. has joined the company as President. Dr. Rollo was formerly Chief Medical Officer of Philips Medical Systems, a global leader in diagnostic imaging systems and healthcare information technology solutions. Cell>Point has licensed five radiopharmaceutical technology platforms from The University of Texas M.D…

Read More

Cell>Point expands clinical trial for Imaging Myocardial Viability — 6|1|06

Posted on: April 14th, 2012

CENTENNIAL, Colo., June 1, 2006 -Cell>Point today announced it plans to start a Phase II clinical trial to evaluate the effectiveness of its 99mTc-EC-DG (Technetium-99m-Ethylenedicys-teine-Deoxyglucose) in diagnosing the presence of viable tissue in regions of the myocardium damaged by myocardial infarction or chronic coronary artery disease. The company has completed the Phase I safety trial on 99mTc-EC-DG…

Read More

Cell>Point named Biotech Rising Star of the Year — 11|8|05

Posted on: April 14th, 2012

ENGLEWOOD, Colorado – November, 8, 2005 – Cell>Point was named Biotech “Rising Star of the Year” by the Colorado BioScience Association.

Read More

Cell>Point acquires Oligosaccharide Conjugate License — 6|3|05

Posted on: April 14th, 2012

HOUSTON, Texas – June 3, 2005 – Cell>Point obtained the worldwide patent and technology license to Oligosaccharide Conjugates for Dual Imaging and Radio/Chemotherapy developed at The University of Texas M. D. Anderson Cancer Center. This novel technology is facilitating the development of combination modality diagnostic imaging agents and new combination radio/chemotherapeutic agents for use in…

Read More

NEWS Cell>Point featured in Aunt Minnie — 5|20|05

Posted on: April 14th, 2012

ENGLEWOOD,Colorado-May20,2005-Cell>Point was featured in the following Aunt Minnie article Biotech firm Cell>Point sees promise for oncology SPECT 1/20/2005 By: Kate Madden Yee Since PET imaging was introduced in the 1990s, its advocates have slowly but surely established a place for the technology, so much so that PET is now considered by many to be the…

Read More

EC Technology featured in Basel, Switzerland — 4|21|05

Posted on: April 14th, 2012

HOUSTON, Texas – April 21, 2005 – Cell>Point announced today that David J. Yang, Ph.D. will present our EC Technology at the Joint Meeting of the Austrian, German, and Swiss Societies of Nuclear Medicine to be held in Basel, Switzerland (April 27-30, 2005).

Read More